![](https://newsheater.com/wp-content/uploads/2020/01/Image-119.png)
CRISPR Therapeutics AG (CRSP) Shares Up Despite Recent Market Volatility
The stock of CRISPR Therapeutics AG (NASDAQ: CRSP) has increased by 0.49 when compared to last closing price of 45.03.Despite this, the company has seen
The stock of CRISPR Therapeutics AG (NASDAQ: CRSP) has increased by 0.49 when compared to last closing price of 45.03.Despite this, the company has seen
The stock has a 36-month beta value of 1.68. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 1 as
The stock of CRISPR Therapeutics AG (NASDAQ: CRSP) has increased by 1.87 when compared to last closing price of 49.07. Despite this, the company has
The stock of CRISPR Therapeutics AG (CRSP) has seen a -1.67% decrease in the past week, with a -25.93% drop in the past month, and
Moreover, the 36-month beta value for CRSP is 1.70. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 1
The stock has a 36-month beta value of 1.69. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 1 as
The stock of CRISPR Therapeutics AG (NASDAQ: CRSP) has decreased by -3.15 when compared to last closing price of 57.19. Despite this, the company has
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.